SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples
Conroy, Andrew, Stockett, David E, Walker, Duncan, Arkin, Michelle R, Hoch, Ute, Fox, Judith A, Hawtin, Rachael Elizabeth
Published in Cancer chemotherapy and pharmacology (01.09.2009)
Published in Cancer chemotherapy and pharmacology (01.09.2009)
Get full text
Journal Article